UPCommons. Portal del coneixement obert de la UPC
Publicación
Artículo científico (JournalArticle)
Atomic-level mechanisms of abnormal activation in NRAS oncogenes from two dimensional free energy landscapes
The NRAS-mutant subset of melanoma is one of the most aggressive and lethal types associated with poor overall survival. Unfortunately, a low understanding of the NRAS-mutant dynamic behavior has lead to the lack of clinically approved therapeutic agents able to directly target NRAS oncogenes. In this work, accurate local structures of NRAS and its mutants have been fully explored through the corresponding free energy surfaces obtained by microsecond scale well-tempered metadynamics simulations. Free energy calculations are crucial to reveal the precise mechanisms of Q61 mutations at the atomic level. Considering specific atom-atom distances
and angles as appropriate reaction coordinates, we have obtained free energy surfaces revealing local and global minima together with their main transitions states, unveiling the mechanisms of abnormal NRAS activation from atomic-level and quantitatively analyzing the corresponding stable states. This will help to advance in our understanding of the basic mechanisms of NRAS mutations, offering new opportunities for the design of potential inhibitors., We are thankful for the financial support provided by the Spanish Ministry of Science, Innovation and Universities (funds MCIU/AEI/FEDER, EU). This publication is a part of the I + D + i project number PID2021-124297NB-C32, funded by MCIN/AEI/10.13039/501100011033/ and “FEDER Una manera de hacer Europa”. Zheyao Hu is a Ph.D. fellow from the Chinese Scholarship Council (grant 202006230070). J. M. thanks the Generalitat de Catalunya for the support through the grant Grup de Recerca SGR-Cat2021 Condensed, Complex and Quantum Matter Group reference 2021SGR-01411 and the Polytechnic University of Catalonia-Barcelona Tech through the funding AGRUPS. Computational resources awarded by the Barcelona Supercomputing Center-Spanish Supercomputing Network (grant BCV-2024-2-0005 “Simulation and modeling of biosystems with applications to medicine (1): drug design for the treatment of cancers of the RAS family”) are also acknowledged., Peer Reviewed